Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Lingo01:11

Genetic Lingo

117.1K
Overview
117.1K
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

599
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
599
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

142
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
142
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

643
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643
Allergic Reactions02:06

Allergic Reactions

33.4K
Overview
33.4K
Angina I: Introduction01:30

Angina I: Introduction

665
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
665

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adipose Tissue Memory and Why Patients Regain Weight after Weight Loss: Understanding the Immunologic Basis for Recurrent Cardiovascular Risk.

Cardiology in review·2026
Same author

Nonocclusive Mesenteric Ischemia in Cardiogenic Shock: Mechanisms of Splanchnic Hypoperfusion and Strategies for Early Detection.

Cardiology in review·2026
Same author

Understanding Dysfunctional Autophagy and Mitophagy in Inflammatory Cardiovascular Disease.

Cardiology in review·2026
Same author

The Cardiopulmonary Complications of Vaping.

Cardiology in review·2026
Same author

Transplant Allograft Markers of Rejection for Heart, Liver, and Kidney Transplantation: A Review.

Cardiology in review·2026
Same author

Metformin as a Cardioprotective Agent: New Life for an Old Drug?

Cardiology in review·2026
Same journal

Lipid-Lowering Efficacy and Safety of Obicetrapib Alone and as an Add on Therapy: A Meta-Analysis of Randomized Controlled Trials.

Cardiology in review·2026
Same journal

Beta-Blockers Versus Flecainide for Atrial Fibrillation: A First-Line Strategy Review of Efficacy, Safety, and Patient Selection.

Cardiology in review·2026
Same journal

Cerebrovascular Disease in Pregnancy: Epidemiology, Pathophysiology, Risk Factors, Diagnostic and Management Considerations, Long-Term Maternal Outcomes: A Narrative Review.

Cardiology in review·2026
Same journal

Immunometabolism in Cardiovascular Disease: Linking Metabolic Reprogramming to Inflammation, Atherothrombosis, and Clinical Outcomes.

Cardiology in review·2026
Same journal

Cardiotoxicity of Antibody-Drug Conjugates in HER2-Positive Cancer: Beyond Left Ventricular Ejection Fraction Decline.

Cardiology in review·2026
Same journal

Celiac Disease and Cardiovascular Disease: Epidemiology, Mechanisms, and Clinical Challenges.

Cardiology in review·2026
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
07:21

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Published on: September 28, 2015

39.8K

Hereditary Angioedema.

Jefferson Regis1, Manish A Parikh1,2, Todd L Simon1,2

  • 1From the Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY.

Cardiology in Review
|March 20, 2026
PubMed
Summary
This summary is machine-generated.

Hereditary angioedema results from SERPING1 gene mutations, causing C1 esterase inhibitor deficiency and bradykinin system overactivation. Advances improve diagnosis and treatment by targeting this pathway.

Keywords:
C1 inhibitorbradykinincomplement cascadehereditary angioedemakallikreinlectin pathway

More Related Videos

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

15.0K
Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
04:09

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

Published on: June 13, 2025

1.5K

Related Experiment Videos

Last Updated: Mar 21, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
07:21

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Published on: September 28, 2015

39.8K
Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
07:36

Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting

Published on: May 1, 2015

15.0K
Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
04:09

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

Published on: June 13, 2025

1.5K

Area of Science:

  • Immunology
  • Genetics
  • Pharmacology

Background:

  • Hereditary angioedema (HAE) is a rare genetic disorder.
  • It stems from mutations in the SERPING1 gene, leading to C1 esterase inhibitor (C1-INH) deficiency or dysfunction.
  • This deficiency causes uncontrolled activation of the kallikrein-kinin system, resulting in swelling attacks.

Purpose of the Study:

  • To review current knowledge on HAE epidemiology, etiology, and pathophysiology.
  • To highlight how recent understanding has influenced diagnostic and therapeutic strategies.
  • To explore the role of complement pathways and C1-INH in HAE.

Main Methods:

  • Literature review of hereditary angioedema.
  • Analysis of SERPING1 gene mutations and their impact on C1-INH.
  • Discussion of complement pathways (classical, alternative, lectin) and the kallikrein-kinin system.
  • Examination of diagnostic workups and genetic considerations.
  • Review of targeted therapies modulating the bradykinin pathway.

Main Results:

  • SERPING1 mutations are the primary cause of HAE, leading to C1-INH issues.
  • The kallikrein-kinin system plays a central role in HAE pathophysiology.
  • Complement pathways are implicated in the disorder's development.
  • Advances in understanding have led to new diagnostic and therapeutic approaches.
  • Targeting the bradykinin pathway offers promising treatment strategies.

Conclusions:

  • Understanding HAE pathophysiology, including complement and bradykinin systems, is crucial.
  • Genetic factors and C1-INH function are key to HAE.
  • Improved diagnostic and therapeutic strategies, particularly bradykinin pathway modulation, aim to optimize patient outcomes and shorten diagnostic delays.